Embryology, Carnegie Institution of Washington, USA Fetal oocyte attrition is a conserved process of elimination of over two-thirds of embryonic oocytes following meiotic initiation. The molecular basis and rationale of fetal oocyte attrition, a critical determinant of the size of an ovarian oocyte reserve in humans, remains unknown. We now present evidence implicating retrotransposons LINE-1 (L1), activated during epigenetic reprogramming of the embryonic germline, in oocyte attrition in mice. We show that wild-type fetal oocytes possess naturally occurring differential nuclear accumulation of L1 ribonucleoproteins that is further enhanced in L1-overexpressing Mael-null and tet-ORFeus mice. We demonstrate that elevated L1 ribonucleoprotein (RNP) levels correlate with the extent of meiotic defects and fetal oocyte attrition and increased L1 expression in the Mael mutant is associated with oocyte and embryo aneuploidy, embryonic lethality and infertility. Conversely, reverse transcriptase inhibitor AZT had a profound positive effect on the dynamics of fetal oocyte attrition and prevents crossover defects. We propose that fetal oocyte attrition selects oocytes with limited L1 activity, therefore, best suited for the next generation.
